VV-ECMO in severe COVID-19: multidimensional perspectives on the use of a complex treatment
- PMID: 36640787
- PMCID: PMC9833831
- DOI: 10.1016/S2213-2600(22)00487-8
VV-ECMO in severe COVID-19: multidimensional perspectives on the use of a complex treatment
Conflict of interest statement
We declare no competing interests.
Comment on
-
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.Lancet Respir Med. 2023 Feb;11(2):151-162. doi: 10.1016/S2213-2600(22)00403-9. Epub 2022 Nov 16. Lancet Respir Med. 2023. PMID: 36402148 Free PMC article.
References
-
- Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965–1975. - PubMed
-
- Lorusso R, De Piero ME, Mariani S, et al. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00403-9. published online Nov 16. - DOI - PMC - PubMed
-
- Schmidt M, Hajage D, Landoll M, et al. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023 doi: 10.1016/S2213-2600(22)00438-6. published online Jan 11. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical